SI0941252T1 - Enoverizni protitelesni fragmenti anti-p53 in njihova uporaba - Google Patents

Enoverizni protitelesni fragmenti anti-p53 in njihova uporaba

Info

Publication number
SI0941252T1
SI0941252T1 SI9730778T SI9730778T SI0941252T1 SI 0941252 T1 SI0941252 T1 SI 0941252T1 SI 9730778 T SI9730778 T SI 9730778T SI 9730778 T SI9730778 T SI 9730778T SI 0941252 T1 SI0941252 T1 SI 0941252T1
Authority
SI
Slovenia
Prior art keywords
antibody fragments
chain antibody
concerns
restoring
vitro
Prior art date
Application number
SI9730778T
Other languages
English (en)
Inventor
Laurent Bracco
Laurent Debussche
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of SI0941252T1 publication Critical patent/SI0941252T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9730778T 1996-10-29 1997-10-27 Enoverizni protitelesni fragmenti anti-p53 in njihova uporaba SI0941252T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9613176A FR2755144B1 (fr) 1996-10-29 1996-10-29 Fragments d'anticorps a chaine unique anti-p53 et utilisation
PCT/FR1997/001921 WO1998018825A1 (fr) 1996-10-29 1997-10-27 Fragments d'anticorps a chaine unique anti-p53 et utilisations
EP97912262A EP0941252B1 (fr) 1996-10-29 1997-10-27 Fragments d'anticorps a chaine unique anti-p53 et utilisations

Publications (1)

Publication Number Publication Date
SI0941252T1 true SI0941252T1 (sl) 2008-04-30

Family

ID=9497134

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730778T SI0941252T1 (sl) 1996-10-29 1997-10-27 Enoverizni protitelesni fragmenti anti-p53 in njihova uporaba

Country Status (21)

Country Link
US (1) US6852509B1 (sl)
EP (1) EP0941252B1 (sl)
JP (1) JP4371178B2 (sl)
KR (1) KR100874789B1 (sl)
AT (1) ATE380198T1 (sl)
AU (1) AU745530B2 (sl)
BR (1) BR9712575A (sl)
CA (1) CA2268865C (sl)
CZ (1) CZ300526B6 (sl)
DE (1) DE69738352T2 (sl)
DK (1) DK0941252T3 (sl)
ES (1) ES2297853T3 (sl)
FR (1) FR2755144B1 (sl)
HU (1) HU226330B1 (sl)
IL (2) IL129476A0 (sl)
NO (1) NO326452B1 (sl)
PT (1) PT941252E (sl)
SI (1) SI0941252T1 (sl)
SK (1) SK286978B6 (sl)
WO (1) WO1998018825A1 (sl)
ZA (1) ZA979738B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121041A0 (en) 1997-06-09 1997-11-20 Yeda Res & Dev Immunogenic compositions for induction of anti-tumor immunity
US7199809B1 (en) 1998-10-19 2007-04-03 Symyx Technologies, Inc. Graphic design of combinatorial material libraries
AU769679B2 (en) * 1999-03-19 2004-01-29 St Vincent's Hospital Sydney Limited Anti-p53 antibodies
AUPP932199A0 (en) * 1999-03-19 1999-04-15 St Vincent's Hospital Sydney Limited Anti-p53 antibodies
DE19962583A1 (de) * 1999-12-23 2001-06-28 Mueller Hermelink Hans Konrad Antikörper gegen Plasmazellen
US6630584B1 (en) * 2000-03-16 2003-10-07 Ramot At Tel-Aviv University Ltd. Single chain antibody against mutant p53
US20080039409A1 (en) * 2003-12-24 2008-02-14 Locomogene, Inc. Method of Suppressing Cancer
JPWO2005061007A1 (ja) * 2003-12-24 2007-07-12 学校法人 聖マリアンナ医科大学 癌の抑制方法
GB0420771D0 (en) * 2004-09-17 2004-10-20 Randox Lab Ltd Antibody
WO2006100681A2 (en) * 2005-03-25 2006-09-28 Ramot At Tel Aviv University Ltd. Human synthetic single-chain antibodies directed against the common epitope of mutant p53 and their uses
WO2007028117A2 (en) * 2005-09-02 2007-03-08 New England Medical Center Hospitals, Inc. P8 as a marker for heart failure
JP7481726B2 (ja) * 2016-05-02 2024-05-13 プロセナ バイオサイエンシーズ リミテッド タウ認識抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224784D0 (en) * 1992-11-26 1993-01-13 Univ Dundee Cellular protein
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
FR2736915B1 (fr) * 1995-07-19 1997-08-22 Rhone Poulenc Rorer Sa Variants de la proteine p53 et utilisations therapeutiques

Also Published As

Publication number Publication date
NO326452B1 (no) 2008-12-08
DE69738352D1 (de) 2008-01-17
ATE380198T1 (de) 2007-12-15
ZA979738B (en) 1998-05-22
HU226330B1 (en) 2008-09-29
KR100874789B1 (ko) 2008-12-18
AU745530B2 (en) 2002-03-21
CZ145599A3 (cs) 1999-08-11
SK55899A3 (en) 2000-06-12
IL129476A (en) 2010-05-17
JP4371178B2 (ja) 2009-11-25
AU4952097A (en) 1998-05-22
DK0941252T3 (da) 2008-03-31
CA2268865C (fr) 2011-01-04
WO1998018825A1 (fr) 1998-05-07
JP2001502553A (ja) 2001-02-27
ES2297853T3 (es) 2008-05-01
BR9712575A (pt) 1999-10-19
CA2268865A1 (fr) 1998-05-07
SK286978B6 (sk) 2009-08-06
FR2755144A1 (fr) 1998-04-30
NO991729L (no) 1999-04-13
US6852509B1 (en) 2005-02-08
HUP9904199A1 (hu) 2000-04-28
IL129476A0 (en) 2000-02-29
NO991729D0 (no) 1999-04-13
HUP9904199A3 (en) 2000-09-28
KR20000052845A (ko) 2000-08-25
FR2755144B1 (fr) 1998-11-27
EP0941252A1 (fr) 1999-09-15
PT941252E (pt) 2008-03-07
DE69738352T2 (de) 2008-11-13
EP0941252B1 (fr) 2007-12-05
CZ300526B6 (cs) 2009-06-10

Similar Documents

Publication Publication Date Title
GB2338237A (en) In vitro peptide or protein expression library
CA2282497A1 (en) In vitro peptide or protein expression library
EP0804609A4 (en) NEW GENES OF RESPONSE p53
EP1712623A3 (en) Selection of proteins using RNA-protein fusions
EP0845032A3 (en) Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
ZA979738B (en) Single-chain anti-P53 antibody fragments, and uses.
DE69839444D1 (de) Smad 6 und dessen anwendungen
WO1998021343A8 (en) Genes encoding telomerase proteins
WO1996007738A3 (en) Modified human c3 proteins
AU1666895A (en) Method for preparing a multicombinatorial library of antibody gene expression vectors
EP1012603A4 (en) FUNCTIONAL FRAGMENTS OF THE HIV-1 VPR PROTEIN AND METHODS OF USE
EP0911397A4 (en) TUMORANTANT PROTEINS, THEIR GENES, AND TUMORANTANT PEPTIDES
WO1999019470A3 (en) Gfp-annexin fusion proteins
AU1727597A (en) Purified sr-p70 protein
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2002012541A3 (en) Novel motor proteins and methods for their use
NZ512332A (en) Potassium channel interactors and uses therefor
WO2004089973A3 (en) Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
WO2001000874A3 (en) Cancer associated antigens and uses therefor
MXPA03002557A (es) Interactores de canales del potasio y sus usos.
WO2001021794A3 (en) Smad associating polypeptides
MX9701904A (es) Proteinas de enlace de pka novedosas y usos de las mismas.
AU714548C (en) Tumor antigen proteins, genes therefor, and tumor antigen peptides
WO2001098314A3 (en) Novel motor proteins and methods for their use
AU4624997A (en) Nematode proteins, dna sequences coding therefor, their specific antibodies and their use in identifying nematicidal active substances